TreeWAS – Variant ID: rs610604

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.072	0.928	0.000
T39.1 4-Aminophenol derivatives	0.072	0.928	0.000
T39.0 Salicylates	0.067	0.933	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.066	0.934	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.057	0.943	0.000
T39.4 Antirheumatics, not elsewhere classified	0.052	0.948	0.000
T39.2 Pyrazolone derivatives	0.052	0.948	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.051	0.949	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.050	0.950	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.045	0.955	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.044	0.956	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.043	0.957	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.041	0.959	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.040	0.960	0.000
T36 Poisoning by systemic antibiotics	0.039	0.961	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.039	0.961	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.039	0.961	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.038	0.962	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.038	0.962	0.000
T50.1 Loop [high-ceiling] diuretics	0.037	0.962	0.000
T45.2 Vitamins, not elsewhere classified	0.037	0.962	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.037	0.963	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.036	0.964	0.000
T42.1 Iminostilbenes	0.036	0.964	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.035	0.965	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.035	0.965	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.035	0.965	0.000
T40.2 Other opioids	0.035	0.965	0.000
T42.4 Benzodiazepines	0.034	0.966	0.000
T45.0 Antiallergic and antiemetic drugs	0.034	0.966	0.000
T38.1 Thyroid hormones and substitutes	0.033	0.966	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.033	0.967	0.000
T42.3 Barbiturates	0.033	0.967	0.000
T50.7 Analeptics and opioid receptor antagonists	0.032	0.967	0.000
T50.5 Appetite depressants	0.032	0.967	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.032	0.967	0.000
T50.0 Mineralocorticoids and their antagonists	0.032	0.967	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.032	0.968	0.000
T45.4 Iron and its compounds	0.032	0.968	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.032	0.968	0.000
T38.0 Glucocorticoids and synthetic analogues	0.032	0.968	0.000
T50.8 Diagnostic agents	0.032	0.968	0.000
T50.4 Drugs affecting uric acid metabolism	0.032	0.968	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.032	0.968	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.032	0.968	0.000
T45.5 Anticoagulants	0.032	0.968	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.031	0.968	0.000
T45.8 Other primarily systemic and haematological agents	0.031	0.968	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.031	0.968	0.000
T45.6 Fibrinolysis-affecting drugs	0.031	0.968	0.000
T45.3 Enzymes, not elsewhere classified	0.031	0.968	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.031	0.969	0.000
T42.2 Succinimides and oxazolidinediones	0.031	0.969	0.000
T36.8 Other systemic antibiotics	0.031	0.969	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.030	0.969	0.000
T38.5 Other oestrogens and progestogens	0.030	0.970	0.000
T38.9 Other and unspecified hormone antagonists	0.030	0.970	0.000
T38.7 Androgens and anabolic congeners	0.030	0.970	0.000
T38.4 Oral contraceptives	0.030	0.970	0.000
T38.2 Antithyroid drugs	0.030	0.970	0.000
T40.3 Methadone	0.030	0.970	0.000
T36.3 Macrolides	0.030	0.970	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.029	0.971	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.029	0.971	0.000
T49.9 Topical agent, unspecified	0.029	0.971	0.000
T49.8 Other topical agents	0.029	0.971	0.000
T49.7 Dental drugs, topically applied	0.029	0.971	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.029	0.971	0.000
T49.5 Ophthalmological drugs and preparations	0.029	0.971	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.029	0.971	0.000
T49.3 Emollients, demulcents and protectants	0.029	0.971	0.000
T49.2 Local astringents and local detergents	0.029	0.971	0.000
T49.1 Antipruritics	0.029	0.971	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.029	0.971	0.000
T40.1 Heroin	0.029	0.971	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.029	0.971	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.029	0.971	0.000
T40.4 Other synthetic narcotics	0.029	0.971	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.028	0.972	0.000
T36.9 Systemic antibiotic, unspecified	0.028	0.972	0.000
T36.7 Antifungal antibiotics, systemically used	0.028	0.972	0.000
T36.6 Rifamycins	0.028	0.972	0.000
T36.5 Aminoglycosides	0.028	0.972	0.000
T36.2 Chloramphenicol group	0.028	0.972	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.028	0.972	0.000
T46.7 Peripheral vasodilators	0.028	0.972	0.000
T48.5 Anti-common-cold drugs	0.028	0.972	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.028	0.972	0.000
T40.8 Lysergide [LSD]	0.028	0.972	0.000
T40.7 Cannabis (derivatives)	0.028	0.972	0.000
T40.0 Opium	0.028	0.972	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.028	0.972	0.000
T42.0 Hydantoin derivatives	0.028	0.972	0.000
T36.4 Tetracyclines	0.028	0.972	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.027	0.972	0.000
T48.4 Expectorants	0.027	0.972	0.000
T48.3 Antitussives	0.027	0.972	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.027	0.972	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.027	0.972	0.000
T48.0 Oxytocic drugs	0.027	0.972	0.000
T36.0 Penicillins	0.027	0.973	0.000
T41.5 Therapeutic gases	0.026	0.973	0.000
T41.4 Anaesthetic, unspecified	0.026	0.973	0.000
T41.3 Local anaesthetics	0.026	0.973	0.000
T41.2 Other and unspecified general anaesthetics	0.026	0.973	0.000
T41.1 Intravenous anaesthetics	0.026	0.973	0.000
T41.0 Inhaled anaesthetics	0.026	0.973	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.026	0.974	0.000
R00.2 Palpitations	0.026	0.974	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.025	0.974	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.025	0.974	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.025	0.975	0.000
T37.5 Antiviral drugs	0.025	0.975	0.000
T37.4 Anthelminthics	0.025	0.975	0.000
T37.3 Other antiprotozoal drugs	0.025	0.975	0.000
T37.1 Antimycobacterial drugs	0.025	0.975	0.000
T37.0 Sulphonamides	0.025	0.975	0.000
T46.1 Calcium-channel blockers	0.025	0.975	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.025	0.975	0.000
T40.5 Cocaine	0.025	0.975	0.000
T47.6 Antidiarrhoeal drugs	0.025	0.975	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.024	0.975	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.024	0.976	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.024	0.976	0.000
T47.7 Emetics	0.024	0.976	0.000
T47.5 Digestants	0.024	0.976	0.000
T47.3 Saline and osmotic laxatives	0.024	0.976	0.000
T47.0 Histamine H(2)-receptor antagonists	0.024	0.976	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.023	0.977	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.022	0.978	0.000
T47.4 Other laxatives	0.021	0.979	0.000
T47.2 Stimulant laxatives	0.021	0.979	0.000
T40.6 Other and unspecified narcotics	0.019	0.981	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.018	0.981	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.018	0.982	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.018	0.982	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.018	0.982	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.018	0.982	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.018	0.982	0.000
T44.0 Anticholinesterase agents	0.018	0.982	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.017	0.983	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.017	0.983	0.000
E10.3 With ophthalmic complications	0.016	0.984	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.012	0.988	0.000
J81 Pulmonary oedema	0.000	0.989	0.011
Z29.2 Other prophylactic chemotherapy	0.000	0.992	0.008
I44.2 Atrioventricular block, complete	0.000	0.992	0.008
O69.8 Labour and delivery complicated by other cord complications	0.000	0.992	0.008
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.008	0.992	0.000
J80-J84 Other respiratory diseases principally affecting the interstitium	0.000	0.992	0.008
J82 Pulmonary eosinophilia, not elsewhere classified	0.000	0.992	0.007
Z29 Need for other prophylactic measures	0.000	0.993	0.007
Z29.8 Other specified prophylactic measures	0.000	0.993	0.007
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.006	0.993	0.001
T43.6 Psychostimulants with abuse potential	0.006	0.994	0.000
D22.0 Melanocytic naevi of lip	0.000	0.994	0.006
J80 Adult respiratory distress syndrome	0.000	0.994	0.006
Z29.1 Prophylactic immunotherapy	0.000	0.994	0.006
T43.4 Butyrophenone and thioxanthene neuroleptics	0.006	0.994	0.000
Z29.0 Isolation	0.000	0.994	0.006
T43.8 Other psychotropic drugs, not elsewhere classified	0.006	0.994	0.000
J84.8 Other specified interstitial pulmonary diseases	0.000	0.994	0.006
T43.9 Psychotropic drug, unspecified	0.005	0.994	0.000
Z29.9 Prophylactic measure, unspecified	0.000	0.995	0.005
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.005	0.995	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.005	0.995	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.005	0.995	0.000
J84 Other interstitial pulmonary diseases	0.000	0.995	0.005
E21.0 Primary hyperparathyroidism	0.005	0.995	0.000
N43.3 Hydrocele, unspecified	0.005	0.995	0.000
E10.5 With peripheral circulatory complications	0.004	0.996	0.000
J84.0 Alveolar and parietoalveolar conditions	0.000	0.996	0.004
E10 Insulin-dependent diabetes mellitus	0.004	0.996	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.003	0.996	0.000
Y52 Agents primarily affecting the cardiovascular system	0.003	0.997	0.000
C15.5 Lower third of oesophagus	0.000	0.997	0.003
T83.8 Other complications of genito-urinary prosthetic devices, implants and grafts	0.003	0.997	0.000
L30.8 Other specified dermatitis	0.003	0.997	0.000
Y52.1 Calcium-channel blockers	0.003	0.997	0.000
R22.9 Localised swelling, mass and lump, unspecified	0.003	0.997	0.000
E10.7 With multiple complications	0.003	0.997	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.003	0.997	0.000
N95.8 Other specified menopausal and perimenopausal disorders	0.003	0.997	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.003	0.997	0.000
E10.8 With unspecified complications	0.003	0.997	0.000
E10.2 With renal complications	0.003	0.997	0.000
T43.2 Other and unspecified antidepressants	0.003	0.997	0.000
E10.6 With other specified complications	0.003	0.997	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.003	0.997	0.000
O68.8 Labour and delivery complicated by other evidence of foetal stress	0.000	0.997	0.003
M89.86 Other specified disorders of bone (Lower leg)	0.000	0.997	0.003
Y52.8 Antivaricose drugs, including sclerosing agents	0.003	0.997	0.000
R31 Unspecified haematuria	0.003	0.997	0.000
Y52.7 Peripheral vasodilators	0.003	0.997	0.000
E10.4 With neurological complications	0.003	0.997	0.000
N43 Hydrocele and spermatocele	0.003	0.997	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.003	0.997	0.000
I44.6 Other and unspecified fascicular block	0.000	0.997	0.003
Q82.8 Other specified congenital malformations of skin	0.000	0.997	0.003
I44 Atrioventricular and left bundle-branch block	0.000	0.997	0.003
N43.4 Spermatocele	0.002	0.997	0.000
S92.00 Fracture of calcaneus (closed)	0.002	0.998	0.000
Z20-Z29 Persons with potential health hazards related to communicable diseases	0.000	0.998	0.002
C85.1 B-cell lymphoma, unspecified	0.002	0.998	0.000
G93.4 Encephalopathy, unspecified	0.000	0.998	0.002
O99.2 Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium	0.000	0.998	0.002
T43.0 Tricyclic and tetracyclic antidepressants	0.002	0.998	0.000
N43.1 Infected hydrocele	0.002	0.998	0.000
G93.0 Cerebral cysts	0.000	0.998	0.002
L30 Other dermatitis	0.002	0.998	0.000
G93.2 Benign intracranial hypertension	0.000	0.998	0.002
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.002	0.998	0.000
I44.7 Left bundle-branch block, unspecified	0.000	0.998	0.002
I44.4 Left anterior fascicular block	0.000	0.998	0.002
N43.0 Encysted hydrocele	0.002	0.998	0.000
Z20 Contact with and exposure to communicable diseases	0.000	0.998	0.002
E10.1 With ketoacidosis	0.002	0.998	0.000
E10.0 With coma	0.002	0.998	0.000
V04.1 Traffic accident	0.002	0.998	0.000
N35.9 Urethral stricture, unspecified	0.002	0.998	0.000
G93 Other disorders of brain	0.000	0.998	0.002
N43.2 Other hydrocele	0.002	0.998	0.000
M81.99 Osteoporosis, unspecified (Site unspecified)	0.002	0.998	0.000
I44.5 Left posterior fascicular block	0.000	0.998	0.002
L30.4 Erythema intertrigo	0.002	0.998	0.000
L92.3 Foreign body granuloma of skin and subcutaneous tissue	0.002	0.998	0.000
L30.0 Nummular dermatitis	0.002	0.998	0.000
Z26 Need for immunisation against other single infectious diseases	0.000	0.998	0.002
G93.5 Compression of brain	0.000	0.998	0.002
G93.1 Anoxic brain damage, not elsewhere classified	0.000	0.998	0.002
Z20.8 Contact with and exposure to other communicable diseases	0.000	0.998	0.002
Z28 Immunisation not carried out	0.000	0.998	0.002
Z27 Need for immunisation against combinations of infectious diseases	0.000	0.998	0.002
Z25 Need for immunisation against other single viral diseases	0.000	0.998	0.002
Z23 Need for immunisation against single bacterial diseases	0.000	0.998	0.002
R90.0 Intracranial space-occupying lesion	0.000	0.998	0.002
Y88.3 Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient or of later complication, without mention of misadventure at the time of the procedure	0.002	0.998	0.000
W06.0 Home	0.002	0.998	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.002	0.998	0.000
L30.1 Dyshidrosis [pompholyx]	0.002	0.998	0.000
D22.9 Melanocytic naevi, unspecified	0.000	0.998	0.002
Z24 Need for immunisation against certain single viral diseases	0.000	0.998	0.002
G90.0 Idiopathic peripheral autonomic neuropathy	0.000	0.998	0.002
L30.5 Pityriasis alba	0.002	0.998	0.000
L30.2 Cutaneous autosensitisation	0.002	0.998	0.000
L30.3 Infective dermatitis	0.002	0.998	0.000
M81.90 Osteoporosis, unspecified (Multiple sites)	0.002	0.998	0.000
S61.8 Open wound of other parts of wrist and hand	0.002	0.998	0.000
C15.4 Middle third of oesophagus	0.000	0.998	0.002
Z22.5 Carrier of viral hepatitis	0.000	0.998	0.002
Q65.8 Other congenital deformities of hip	0.002	0.998	0.000
C15 Malignant neoplasm of oesophagus	0.000	0.998	0.002
C15.3 Upper third of oesophagus	0.000	0.998	0.002
Z26.9 Need for immunisation against unspecified infectious disease	0.000	0.998	0.002
Z21 Asymptomatic human immunodeficiency virus [HIV] infection status	0.000	0.998	0.002
N21.0 Calculus in bladder	0.002	0.998	0.000
Z20.9 Contact with and exposure to unspecified communicable disease	0.000	0.998	0.002
Z20.7 Contact with and exposure to pediculosis, acariasis and other infestations	0.000	0.998	0.002
Z20.6 Contact with and exposure to human immunodeficiency virus [HIV]	0.000	0.998	0.002
Z20.5 Contact with and exposure to viral hepatitis	0.000	0.998	0.002
Z20.4 Contact with and exposure to rubella	0.000	0.998	0.002
Z20.3 Contact with and exposure to rabies	0.000	0.998	0.002
Z20.2 Contact with and exposure to infections with a predominantly sexual mode of transmission	0.000	0.998	0.002
Z20.1 Contact with and exposure to tuberculosis	0.000	0.998	0.002
Z20.0 Contact with and exposure to intestinal infectious diseases	0.000	0.998	0.002
G93.7 Reye's syndrome	0.000	0.998	0.002
L23.1 Allergic contact dermatitis due to adhesives	0.002	0.998	0.000
G90.2 Horner's syndrome	0.000	0.998	0.002
E83.4 Disorders of magnesium metabolism	0.000	0.998	0.002
J93.9 Pneumothorax, unspecified	0.000	0.998	0.002
K11.2 Sialoadenitis	0.002	0.998	0.000
O20.9 Haemorrhage in early pregnancy, unspecified	0.002	0.998	0.000
N88.9 Noninflammatory disorder of cervix uteri, unspecified	0.002	0.998	0.000
Z26.8 Need for immunisation against other specified single infectious diseases	0.000	0.998	0.002
Z26.0 Need for immunisation against leishmaniasis	0.000	0.998	0.002
I44.1 Atrioventricular block, second degree	0.000	0.998	0.002
J84.9 Interstitial pulmonary disease, unspecified	0.000	0.998	0.002
Z23.8 Need for immunisation against other single bacterial diseases	0.000	0.998	0.001
Z23.7 Need for immunisation against pertussis alone	0.000	0.998	0.001
Z23.6 Need for immunisation against diphtheria alone	0.000	0.998	0.001
Z23.5 Need for immunisation against tetanus alone	0.000	0.998	0.001
Z23.4 Need for immunisation against tularaemia	0.000	0.998	0.001
Z23.3 Need for immunisation against plague	0.000	0.998	0.001
Z23.2 Need for immunisation against tuberculosis [BCG]	0.000	0.998	0.001
Z23.1 Need for immunisation against typhoid-paratyphoid alone [TAB]	0.000	0.998	0.001
Z23.0 Need for immunisation against cholera alone	0.000	0.998	0.001
Z25.8 Need for immunisation against other specified single viral diseases	0.000	0.998	0.001
Z25.1 Need for immunisation against influenza	0.000	0.998	0.001
Z25.0 Need for immunisation against mumps alone	0.000	0.998	0.001
Z27.9 Need for immunisation against unspecified combinations of infectious diseases	0.000	0.998	0.001
Z27.8 Need for immunisation against other combinations of infectious diseases	0.000	0.998	0.001
Z27.4 Need for immunisation against measles-mumps-rubella [MMR]	0.000	0.998	0.001
Z27.3 Need for immunisation against diphtheria-tetanus-pertussis with poliomyelitis [DTP + polio]	0.000	0.998	0.001
Z27.2 Need for immunisation against diphtheria-tetanus-pertussis with typhoid-paratyphoid [DTP + TAB]	0.000	0.998	0.001
Z27.1 Need for immunisation against diphtheria-tetanus-pertussis, combined [DTP]	0.000	0.998	0.001
Z27.0 Need for immunisation against cholera with typhoid-paratyphoid [cholera + TAB]	0.000	0.998	0.001
Z28.9 Immunisation not carried out for unspecified reason	0.000	0.998	0.001
Z28.8 Immunisation not carried out for other reasons	0.000	0.998	0.001
Z28.2 Immunisation not carried out because of patient's decision for other and unspecified reasons	0.000	0.998	0.001
Z28.1 Immunisation not carried out because of patient's decision for reasons of belief or group pressure	0.000	0.998	0.001
Z28.0 Immunisation not carried out because of contraindication	0.000	0.998	0.001
Q82 Other congenital malformations of skin	0.000	0.998	0.002
L23 Allergic contact dermatitis	0.002	0.998	0.000
H05.2 Exophthalmic conditions	0.002	0.998	0.000
I44.3 Other and unspecified atrioventricular block	0.000	0.998	0.002
S37.00 Injury of kidney (without open wound into cavity)	0.000	0.998	0.002
H11.0 Pterygium	0.000	0.998	0.002
Z24.6 Need for immunisation against viral hepatitis	0.000	0.998	0.001
Z24.4 Need for immunisation against measles alone	0.000	0.998	0.001
Z24.3 Need for immunisation against yellow fever	0.000	0.998	0.001
Z24.2 Need for immunisation against rabies	0.000	0.998	0.001
Z24.1 Need for immunisation against arthropod-borne viral encephalitis	0.000	0.998	0.001
Z24.0 Need for immunisation against poliomyelitis	0.000	0.998	0.001
M45.X9 Ankylosing spondylitis (Site unspecified)	0.000	0.998	0.002
C15.8 Overlapping lesion of oesophagus	0.000	0.998	0.001
C15.2 Abdominal part of oesophagus	0.000	0.998	0.001
C15.1 Thoracic part of oesophagus	0.000	0.998	0.001
G93.3 Postviral fatigue syndrome	0.000	0.998	0.002
Z42.2 Follow-up care involving plastic surgery of other parts of trunk	0.002	0.998	0.000
M89.81 Other specified disorders of bone (Shoulder region)	0.000	0.998	0.002
A49.9 Bacterial infection, unspecified	0.002	0.998	0.000
L27.1 Localised skin eruption due to drugs and medicaments	0.002	0.998	0.000
Q82.2 Mastocytosis	0.000	0.998	0.001
L23.0 Allergic contact dermatitis due to metals	0.001	0.998	0.000
Z24.5 Need for immunisation against rubella alone	0.000	0.998	0.001
L20-L30 Dermatitis and eczema	0.002	0.998	0.000
G93.6 Cerebral oedema	0.000	0.998	0.002
D04.3 Skin of other and unspecified parts of face	0.002	0.998	0.000
F34.1 Dysthymia	0.000	0.998	0.002
M89.8 Other specified disorders of bone	0.000	0.998	0.002
O12.0 Gestational oedema	0.000	0.998	0.002
F41.0 Panic disorder [episodic paroxysmal anxiety]	0.000	0.998	0.002
I88.9 Nonspecific lymphadenitis, unspecified	0.000	0.998	0.002
N88.1 Old laceration of cervix uteri	0.002	0.998	0.000
L28 Lichen simplex chronicus and prurigo	0.002	0.998	0.000
M89.89 Other specified disorders of bone (Site unspecified)	0.000	0.998	0.001
L23.8 Allergic contact dermatitis due to other agents	0.001	0.998	0.000
L23.7 Allergic contact dermatitis due to plants, except food	0.001	0.998	0.000
L23.6 Allergic contact dermatitis due to food in contact with the skin	0.001	0.998	0.000
L23.4 Allergic contact dermatitis due to dyes	0.001	0.998	0.000
L23.2 Allergic contact dermatitis due to cosmetics	0.001	0.998	0.000
Q82.9 Congenital malformation of skin, unspecified	0.000	0.998	0.001
Q82.4 Ectodermal dysplasia (anhidrotic)	0.000	0.998	0.001
Q82.3 Incontinentia pigmenti	0.000	0.998	0.001
Q82.1 Xeroderma pigmentosum	0.000	0.998	0.001
Q82.0 Hereditary lymphoedema	0.000	0.998	0.001
S92.0 Fracture of calcaneus	0.001	0.998	0.000
L27 Dermatitis due to substances taken internally	0.001	0.998	0.000
M81.96 Osteoporosis, unspecified (Lower leg)	0.001	0.999	0.000
M81.92 Osteoporosis, unspecified (Upper arm)	0.001	0.999	0.000
S92.01 Fracture of calcaneus (open)	0.001	0.999	0.000
K22.0 Achalasia of cardia	0.000	0.999	0.001
L23.5 Allergic contact dermatitis due to other chemical products	0.001	0.999	0.000
Z35.5 Supervision of elderly primigravida	0.000	0.999	0.001
L23.9 Allergic contact dermatitis, unspecified cause	0.001	0.999	0.000
Q85.8 Other phakomatoses, not elsewhere classified	0.000	0.999	0.001
V04 Pedestrian injured in collision with heavy transport vehicle or bus	0.001	0.999	0.000
M79.57 Residual foreign body in soft tissue (Ankle and foot)	0.001	0.999	0.000
L23.3 Allergic contact dermatitis due to drugs in contact with the skin	0.001	0.999	0.000
M89.85 Other specified disorders of bone (Pelvic region and thigh)	0.000	0.999	0.001
J35.0 Chronic tonsillitis	0.000	0.999	0.001
L28.2 Other prurigo	0.001	0.999	0.000
O20.0 Threatened abortion	0.001	0.999	0.000
L21 Seborrhoeic dermatitis	0.001	0.999	0.000
J84.1 Other interstitial pulmonary diseases with fibrosis	0.000	0.999	0.001
L28.1 Prurigo nodularis	0.001	0.999	0.000
C15.0 Cervical part of oesophagus	0.000	0.999	0.001
G93.9 Disorder of brain, unspecified	0.000	0.999	0.001
G93.8 Other specified disorders of brain	0.000	0.999	0.001
M81.9 Osteoporosis, unspecified	0.001	0.999	0.000
Z80.8 Family history of malignant neoplasm of other organs or systems	0.000	0.999	0.001
L24 Irritant contact dermatitis	0.001	0.999	0.000
L22 Diaper [napkin] dermatitis	0.001	0.999	0.000
Z22 Carrier of infectious disease	0.000	0.999	0.001
M89.82 Other specified disorders of bone (Upper arm)	0.000	0.999	0.001
M89.80 Other specified disorders of bone (Multiple sites)	0.000	0.999	0.001
Y00.0 Home	0.000	0.999	0.001
O12.1 Gestational proteinuria	0.000	0.999	0.001
Y54.3 Benzothiadiazine derivatives	0.001	0.999	0.000
Q66.8 Other congenital deformities of feet	0.001	0.999	0.000
G90 Disorders of autonomic nervous system	0.000	0.999	0.001
B50.9 Plasmodium falciparum malaria, unspecified	0.000	0.999	0.001
L27.9 Dermatitis due to unspecified substance taken internally	0.001	0.999	0.000
L27.8 Dermatitis due to other substances taken internally	0.001	0.999	0.000
L20 Atopic dermatitis	0.001	0.999	0.000
G90.8 Other disorders of autonomic nervous system	0.000	0.999	0.001
L28.0 Lichen simplex chronicus	0.001	0.999	0.000
Q82.5 Congenital nonneoplastic naevus	0.000	0.999	0.001
Q85.0 Neurofibromatosis (nonmalignant)	0.000	0.999	0.001
V04.9 Unspecified whether traffic or nontraffic accident	0.001	0.999	0.000
V04.0 Nontraffic accident	0.001	0.999	0.000
L26 Exfoliative dermatitis	0.001	0.999	0.000
M81.93 Osteoporosis, unspecified (Forearm)	0.001	0.999	0.000
M89.84 Other specified disorders of bone (Hand)	0.000	0.999	0.001
S22.30 Fracture of rib (closed)	0.001	0.999	0.000
K11.1 Hypertrophy of salivary gland	0.001	0.999	0.000
L21.9 Seborrhoeic dermatitis, unspecified	0.001	0.999	0.000
L21.8 Other seborrhoeic dermatitis	0.001	0.999	0.000
L21.1 Seborrhoeic infantile dermatitis	0.001	0.999	0.000
L21.0 Seborrhoea capitis	0.001	0.999	0.000
N21.1 Calculus in urethra	0.001	0.999	0.000
R82.7 Abnormal findings on microbiological examination of urine	0.001	0.999	0.000
M89.88 Other specified disorders of bone (Other)	0.000	0.999	0.001
G58.9 Mononeuropathy, unspecified	0.001	0.999	0.000
I45.3 Trifascicular block	0.000	0.999	0.001
L20.8 Other atopic dermatitis	0.001	0.999	0.000
L27.0 Generalised skin eruption due to drugs and medicaments	0.001	0.999	0.000
O68.1 Labour and delivery complicated by meconium in amniotic fluid	0.000	0.999	0.001
S92.20 Fracture of other tarsal bone(s) (closed)	0.001	0.999	0.000
C15.9 Oesophagus, unspecified	0.000	0.999	0.001
J05.1 Acute epiglottitis	0.000	0.999	0.001
L24.9 Irritant contact dermatitis, unspecified cause	0.001	0.999	0.000
L24.8 Irritant contact dermatitis due to other agents	0.001	0.999	0.000
L24.7 Irritant contact dermatitis due to plants, except food	0.001	0.999	0.000
L24.6 Irritant contact dermatitis due to food in contact with the skin	0.001	0.999	0.000
L24.5 Irritant contact dermatitis due to other chemical products	0.001	0.999	0.000
L24.4 Irritant contact dermatitis due to drugs in contact with the skin	0.001	0.999	0.000
L24.3 Irritant contact dermatitis due to cosmetics	0.001	0.999	0.000
L24.2 Irritant contact dermatitis due to solvents	0.001	0.999	0.000
L24.1 Irritant contact dermatitis due to oils and greases	0.001	0.999	0.000
L24.0 Irritant contact dermatitis due to detergents	0.001	0.999	0.000
L29.3 Anogenital pruritus, unspecified	0.001	0.999	0.000
O22.0 Varicose veins of lower extremity in pregnancy	0.001	0.999	0.000
Q65.2 Congenital dislocation of hip, unspecified	0.001	0.999	0.000
W06.9 Unspecified place	0.001	0.999	0.000
Z22.9 Carrier of infectious disease, unspecified	0.000	0.999	0.001
Z22.6 Carrier of human T-lymphotropic virus type 1 [HTLV-1] infection	0.000	0.999	0.001
Z22.4 Carrier of infections with a predominantly sexual mode of transmission	0.000	0.999	0.001
Z22.2 Carrier of diphtheria	0.000	0.999	0.001
Z22.0 Carrier of typhoid	0.000	0.999	0.001
Q85 Phakomatoses, not elsewhere classified	0.000	0.999	0.001
S32.50 Fracture of pubis (closed)	0.000	0.999	0.001
L25 Unspecified contact dermatitis	0.001	0.999	0.000
Q65 Congenital deformities of hip	0.001	0.999	0.000
M07.36 Other psoriatic arthropathies (Lower leg)	0.000	0.999	0.001
G90.4 Autonomic dysreflexia	0.000	0.999	0.001
G90.1 Familial dysautonomia [Riley-Day]	0.000	0.999	0.001
K10.0 Developmental disorders of jaws	0.001	0.999	0.000
N13.0 Hydronephrosis with ureteropelvic junction obstruction	0.001	0.999	0.000
A86 Unspecified viral encephalitis	0.000	0.999	0.001
L29 Pruritus	0.001	0.999	0.000
M81.91 Osteoporosis, unspecified (Shoulder region)	0.001	0.999	0.000
M89.83 Other specified disorders of bone (Forearm)	0.000	0.999	0.001
K10.2 Inflammatory conditions of jaws	0.001	0.999	0.000
L20.0 Besnier's prurigo	0.001	0.999	0.000
Z49.1 Extracorporeal dialysis	0.001	0.999	0.000
Q65.9 Congenital deformity of hip, unspecified	0.001	0.999	0.000
Q65.0 Congenital dislocation of hip, unilateral	0.001	0.999	0.000
Q85.1 Tuberous sclerosis	0.000	0.999	0.001
S31.4 Open wound of vagina and vulva	0.000	0.999	0.001
T09.0 Superficial injury of trunk, level unspecified	0.000	0.999	0.001
M81.94 Osteoporosis, unspecified (Hand)	0.001	0.999	0.000
L25.8 Unspecified contact dermatitis due to other agents	0.001	0.999	0.000
L25.5 Unspecified contact dermatitis due to plants, except food	0.001	0.999	0.000
L25.4 Unspecified contact dermatitis due to food in contact with the skin	0.001	0.999	0.000
L25.3 Unspecified contact dermatitis due to other chemical products	0.001	0.999	0.000
L25.2 Unspecified contact dermatitis due to dyes	0.001	0.999	0.000
L25.1 Unspecified contact dermatitis due to drugs in contact with the skin	0.001	0.999	0.000
L25.0 Unspecified contact dermatitis due to cosmetics	0.001	0.999	0.000
L27.2 Dermatitis due to ingested food	0.001	0.999	0.000
O00.9 Ectopic pregnancy, unspecified	0.001	0.999	0.000
Q65.6 Unstable hip	0.001	0.999	0.000
Q65.5 Congenital subluxation of hip, unspecified	0.001	0.999	0.000
Q65.4 Congenital subluxation of hip, bilateral	0.001	0.999	0.000
Q65.3 Congenital subluxation of hip, unilateral	0.001	0.999	0.000
Q65.1 Congenital dislocation of hip, bilateral	0.001	0.999	0.000
M00.97 Pyogenic arthritis, unspecified (Ankle and foot)	0.001	0.999	0.000
E21.4 Other specified disorders of parathyroid gland	0.001	0.999	0.000
L29.1 Pruritus scroti	0.001	0.999	0.000
N20.9 Urinary calculus, unspecified	0.001	0.999	0.000
O20 Haemorrhage in early pregnancy	0.001	0.999	0.000
M89.87 Other specified disorders of bone (Ankle and foot)	0.000	0.999	0.001
G97.0 Cerebrospinal fluid leak from spinal puncture	0.000	0.999	0.001
K10.3 Alveolitis of jaws	0.001	0.999	0.000
M45.X2 Ankylosing spondylitis (Cervical region)	0.000	0.999	0.001
J02.9 Acute pharyngitis, unspecified	0.001	0.999	0.000
L29.9 Pruritus, unspecified	0.001	0.999	0.000
Q85.9 Phakomatosis, unspecified	0.000	0.999	0.001
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.001	0.999	0.000
M81.97 Osteoporosis, unspecified (Ankle and foot)	0.001	0.999	0.000
D39.1 Ovary	0.001	0.999	0.000
F30.9 Manic episode, unspecified	0.000	0.999	0.001
I33.0 Acute and subacute infective endocarditis	0.000	0.999	0.001
L29.2 Pruritus vulvae	0.001	0.999	0.000
N71.9 Inflammatory disease of uterus, unspecified	0.001	0.999	0.000
O02.0 Blighted ovum and nonhydatidiform mole	0.001	0.999	0.000
Y88.0 Sequelae of adverse effects caused by drugs, medicaments and biological substances in therapeutic use	0.001	0.999	0.000
Z22.8 Carrier of other infectious diseases	0.000	0.999	0.001
M79.54 Residual foreign body in soft tissue (Hand)	0.001	0.999	0.000
C18.4 Transverse colon	0.001	0.999	0.000
E21.5 Disorder of parathyroid gland, unspecified	0.001	0.999	0.000
K63.3 Ulcer of intestine	0.001	0.999	0.000
R16.1 Splenomegaly, not elsewhere classified	0.001	0.999	0.000
C91.4 Hairy-cell leukaemia	0.001	0.999	0.000
D59.9 Acquired haemolytic anaemia, unspecified	0.001	0.999	0.000
W28.9 Unspecified place	0.000	0.999	0.001
N21 Calculus of lower urinary tract	0.001	0.999	0.000
Y88 Sequelae of surgical and medical care as external cause	0.001	0.999	0.000
D22.1 Melanocytic naevi of eyelid, including canthus	0.000	0.999	0.001
L20.9 Atopic dermatitis, unspecified	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations